NIH: Clinical Trial Results Support Use of Weekly Extended-Release Buprenorphine for Treatment of Opioid Use Disorder During Pregnancy
March 17, 2026
March 17, 2026
WASHINGTON, March 17 (TNSjou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:
* * *
Clinical trial results support use of weekly extended-release buprenorphine for treatment of opioid use disorder during pregnancy
NIH-supported study shows this treatment resulted in higher rates of illicit opioid abstinence than current standard of care.
*
In a clinical tria . . .
* * *
Clinical trial results support use of weekly extended-release buprenorphine for treatment of opioid use disorder during pregnancy
NIH-supported study shows this treatment resulted in higher rates of illicit opioid abstinence than current standard of care.
*
In a clinical tria . . .